@prefix this: <http://www.tkuhn.ch/bel2nanopub/RA8bAt-wOG_fE2kS-KXynVX-e3K53PV4FcPLM3Rtd-sac> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RA8bAt-wOG_fE2kS-KXynVX-e3K53PV4FcPLM3Rtd-sac#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix chebi: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix mesh: <http://purl.bioontology.org/ontology/MSH/> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 occursIn: mesh:D006321, species:9606;
    rdf:object chebi:26523;
    rdf:predicate belv:decreases;
    rdf:subject chebi:3099;
    a rdf:Statement .
  
  sub:assertion rdfs:label "a(CHEBI:bilirubin) -| a(CHEBI:\"reactive oxygen species\")" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_3;
    pav:version "1.4" .
  
  sub:_2 prov:value " Bilirubin was only recently recognized as a potentially important anti-oxidant of physiological significance (Stocker et al., 1987), although this property had already been known for some time (Bernard et al., 1954). Administration of bilirubin demonstrated to be cytoprotective in models of ischemic heart injury and oxidative damage (Dore et al., 1999; Clark et al., 2000).";
    prov:wasQuotedFrom pubmed:12869663 .
  
  sub:_3 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:12869663;
    prov:wasDerivedFrom beldoc:, sub:_2 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:30:14.801+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}